44 related articles for article (PubMed ID: 8774705)
1. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.
Roux P; Alfieri C; Hrimech M; Cohen EA; Tanner JE
J Virol; 2000 May; 74(10):4658-65. PubMed ID: 10775602
[TBL] [Abstract][Full Text] [Related]
2. Identification and activation mechanism of the interleukin-4-induced nuclear factor binding to the CD23(b) promoter in human B lymphocytes.
Park HJ; Choi YS; Lee CE
Mol Cells; 1997 Dec; 7(6):755-61. PubMed ID: 9509417
[TBL] [Abstract][Full Text] [Related]
3. Targeting Store-Operated Calcium Entry Regulates the Inflammation-Induced Proliferation and Migration of Breast Cancer Cells.
Alqinyah M; Alhamed AS; Alnefaie HO; Algahtani MM; Badr AM; Albogami AM; Mohany M; Alassmrry YA; Alghaith AF; Alhamami HN; Alhazzani K; Alanazi AZ; Alsaidan OA
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371732
[TBL] [Abstract][Full Text] [Related]
4. Integrated Bioluminescent Immunoassays for High-Throughput Sampling and Continuous Monitoring of Cytokines.
van Aalen EA; Rosier BJHM; Jansen T; Wouters SFA; Vermathen RT; van der Veer HJ; Yeste Lozano J; Mughal S; Fernández-Costa JM; Ramón-Azcón J; den Toonder JMJ; Merkx M
Anal Chem; 2023 Jun; 95(23):8922-8931. PubMed ID: 37253113
[TBL] [Abstract][Full Text] [Related]
5. Combined Effects of Eicosapentaenoic Acid and Adipocyte Renin-Angiotensin System Inhibition on Breast Cancer Cell Inflammation and Migration.
Rasha F; Kahathuduwa C; Ramalingam L; Hernandez A; Moussa H; Moustaid-Moussa N
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963198
[TBL] [Abstract][Full Text] [Related]
6. A Stilbenoid Isorhapontigenin as a Potential Anti-Cancer Agent against Breast Cancer through Inhibiting Sphingosine Kinases/Tubulin Stabilization.
Subedi L; Teli MK; Lee JH; Gaire BP; Kim MH; Kim SY
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817453
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.
Shimura T; Shibata M; Gonda K; Murakami Y; Noda M; Tachibana K; Abe N; Ohtake T
Oncol Lett; 2019 Jun; 17(6):5139-5146. PubMed ID: 31186728
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cells.
Malik DE; David RM; Gooderham NJ
Arch Toxicol; 2018 Oct; 92(10):3223-3239. PubMed ID: 30155724
[TBL] [Abstract][Full Text] [Related]
9. Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration.
Kim S; Song JH; Kim S; Qu P; Martin BK; Sehareen WS; Haines DC; Lin PC; Sharan SK; Chang S
Oncotarget; 2016 Mar; 7(10):11094-112. PubMed ID: 26848978
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
[TBL] [Abstract][Full Text] [Related]
11. A signal transducer and activator of transcription 3·Nuclear Factor κB (Stat3·NFκB) complex is necessary for the expression of fascin in metastatic breast cancer cells in response to interleukin (IL)-6 and tumor necrosis factor (TNF)-α.
Snyder M; Huang J; Huang XY; Zhang JJ
J Biol Chem; 2014 Oct; 289(43):30082-9. PubMed ID: 25213863
[TBL] [Abstract][Full Text] [Related]
12. Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway.
Perry DM; Newcomb B; Adada M; Wu BX; Roddy P; Kitatani K; Siskind L; Obeid LM; Hannun YA
J Biol Chem; 2014 Aug; 289(32):22401-12. PubMed ID: 24951586
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic insights into the events that lead to synergistic induction of interleukin 6 transcription upon activation of the aryl hydrocarbon receptor and inflammatory signaling.
DiNatale BC; Schroeder JC; Francey LJ; Kusnadi A; Perdew GH
J Biol Chem; 2010 Aug; 285(32):24388-97. PubMed ID: 20511231
[TBL] [Abstract][Full Text] [Related]
14. Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene.
Gaviraghi M; Caricasole A; Costanzo C; Diamanti D; Dandrea M; Donadelli M; Scarpa A; Palmieri M
BMC Mol Biol; 2008 Jun; 9():56. PubMed ID: 18549468
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells.
Hollingshead BD; Beischlag TV; Dinatale BC; Ramadoss P; Perdew GH
Cancer Res; 2008 May; 68(10):3609-17. PubMed ID: 18483242
[TBL] [Abstract][Full Text] [Related]
16. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription.
Foti D; Iuliano R; Chiefari E; Brunetti A
Mol Cell Biol; 2003 Apr; 23(8):2720-32. PubMed ID: 12665574
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.
Faggioli L; Costanzo C; Merola M; Bianchini E; Furia A; Carsana A; Palmieri M
Eur J Biochem; 1996 Aug; 239(3):624-31. PubMed ID: 8774705
[TBL] [Abstract][Full Text] [Related]
18. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
19. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
